Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12103921 Chemical compounds

Patent 12103921 was granted and assigned to Pfizer on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Olugbeminiyi Omezia Fadeyi0

Lyn Howard Jones0

Ralph Pelton Robinson, Jr.0

Lee Richard Roberts0

Ming Zhu Chen0

Hatice Gizem Yayla0

Chulho Choi0

David Hepworth0

...

Date of Patent

October 1, 2024

0

Patent Application Number

183228440

Date Filed

May 24, 2023

0

Patent Citations

US Patent 9604999 Compounds and uses thereof for the modulation of hemoglobin

0

US Patent 9776960 Compounds and uses thereof for the modulation of hemoglobin

0

US Patent 9981939 Compounds and uses thereof for the modulation of hemoglobin

0

US Patent 10017491 Compounds and uses thereof for the modulation of hemoglobin

0

US Patent 10100040 Compounds and uses thereof for the modulation of hemoglobin

0

US Patent 11702405 Chemical compounds

0

US Patent 11014908 Chemical compounds

0

US Patent 7169797 Protein-tyrosine phosphatase inhibitors and uses thereof

0

...

Patent Primary Examiner

Daniel R Carcanague

0

CPC Code

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12103921 Chemical compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool